Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Journal of Spine Surgery (Hong Kong)|March 21, 2020
Regional variations in acceptance, and utilization of minimally invasive spinal surgery techniques among spine surgeons: results of a global surveyKai-Uwe Lewandrowski, José-Antonio Soriano-Sánchez, Xifeng Zhang, et al.
Neurology (E-Cronicon)|September 29, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical TargetingKenneth Blum, Kavya Mohankumar, Debasis Bagchi, et al.
Gene & Protein in Disease|August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genomeKenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Neurology (E-Cronicon)|March 16, 2026
Neurogenetics and Epigenetics of Spirituality and Religion: Seeking Genospirituality Via the Lens of Hierarchical Neuro-Spiritual Model (HNSM)Kai-Uwe Lewandrowski, Kenneth Blum, Morgan P Lorio, et al.
Frontiers in Public Health|December 3, 2025
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergiaKai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, et al.
Current Pharmaceutical Biotechnology|April 18, 2025
A Comprehensive 4-Layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-Addiction Assessment Tool in the Opioid Crisis EraAlireza Sharafshah, Kai-Uwe Lewandrowski, Igor Elman, et al.
International Journal of Spine Surgery|April 27, 2024
Comparative Analysis of Learning Curve, Complexity, Psychological Stress, and Work Relative Value Units for CPT 62380 Endoscopic Lumbar Spinal Decompression vs Traditional Lumbar Spine Surgeries: A Paired Rasch Survey StudyKai-Uwe Lewandrowski, Heber Humberto Alfaro Pachicano, Rossano Kepler Alvim Fiorelli, et al.
Current Neuropharmacology|January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use DisorderAlireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
Acta Scientific Neurology|September 2, 2025
Dopaminergic Homeostatic Therapy (DHT™) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS®) ScreeningKai-Uwe Lewandrowski, Abdalla Bowirrat, Albert Pinhasov, et al.
British Journal of Healthcare and Medical Research|May 8, 2026
Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?Kenneth Blum, Kai Uwe Lewandrowski, Morgan P Lorio, et al.
Pageof 20